MREO | Mereo BioPharma Group plc
Category: Company
Quick infos Headquarters: United Kingdom Trade prices Volume: Market Cap: 144.45M Prev closed: Open: 2.5 High: 2.59 Low: 2.42 52 week low: 1.9 52 week high: 4.71 Dividends: No Dividends Next ER: March 30, 2022
Company Profile Mereo BioPharma (?Mereo?) was incorporated in March 2015 and is dual-listed on London Stock Exchange?s AIM market (MPH) and NASDAQ (MREO).
Earnings History Date EPS / Forecast Revenue / Forecast August 11, 2021 - / -0.1393- / -June 2, 2021 -0.1393 / -0.1393- / -view more
Historical Data Date Price Open High Low Vol Change ER Mar 30, 2022 1.040 1.200 1.240
1.030
4.39M -21.21% Mar 29, 2022 1.320 1.250 1.340
1.250
187.48K 2.33% Mar 28, 2022 1.290 1.440 1.440
1.250
224.01K -9.15% Mar 25, 2022 1.420 1.290 1.420
1.200
362.68K 14.52% Mar 24, 2022 1.240 1.180 1.320
1.160
689.93K 4.20% Mar 23, 2022 1.190 1.200 1.240
1.137
658.57K -0.83% Mar 22, 2022 1.200 1.230 1.230
1.190
219.60K -0.83% Mar 21, 2022 1.210 1.270 1.270
1.190
124.83K -9.02% Mar 18, 2022 1.330 1.320 1.360
1.290
415.76K 0% Mar 17, 2022 1.330 1.300 1.350
1.280
159.91K 1.53% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Mereo BioPharma Announces Positive Desmosine Biomarker Data from an Interim Analysis of an Investigator Initiated Study of alvelestat in Bronchiolitis Obliterans Syndrome (BOS) finance.yahoo.com Oct 2, 2021 8:00 am Mereo BioPharma, Ultragenyx report secondary endpoint data in trial for bone disorder seekingalpha.com Oct 2, 2021 5:09 am
Mereo BioPharma Group plc Announces Positive Early 6 Month Data from the Open Label Arm of the Phase 2b Clinical Study in Adult Patients with Type I, III or IV Osteogenesis Imperfecta Treated with the Anti-Sclerostin Antibody, BPS-804 (setrusumab) finance.yahoo.com Oct 2, 2021 2:00 am
Mereo BioPharma and Ultragenyx Present Data from the Phase 2b ASTEROID Study of UX143 (setrusumab) in Osteogenesis Imperfecta (OI) at the American Society for Bone and Mineral Research (ASBMR) 2021 Annual Meeting finance.yahoo.com Oct 1, 2021 4:31 pm
Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta finance.yahoo.com Oct 1, 2021 4:05 pm
The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data finance.yahoo.com Oct 1, 2021 7:45 am ZBRA, FGEN, GOOGL and TCOM among after hours movers seekingalpha.com Oct 1, 2021 5:40 am
Mereo BioPharma Announces Equity Investment of $3 Million from New U.S. Institutional Investor finance.yahoo.com Oct 1, 2021 3:00 am Mereo Biopharma adds Pierre Jacquet to board of directors seekingalpha.com Sep 20, 2021 9:12 pm
Mereo BioPharma to Participate in Three Upcoming Investor Conferences finance.yahoo.com Sep 9, 2021 8:00 am Warning: MREO has been downgraded to Very Bearish seekingalpha.com Jul 9, 2021 3:10 pm GameStop Options Bet That the Stock Will Reach $800 on Friday reportdoor.com Feb 26, 2021 11:34 am
Billionaire Ken Griffin Pulls the Trigger on These 2 Penny Stocks finance.yahoo.com Feb 25, 2021 11:33 am
Mereo BioPharma Announces Appointment of Pierre Jacquet, M.D., Ph.D. to Board of Directors finance.yahoo.com Sep 20, 2021 8:00 am
Mereo BioPharma to Participate in a Fireside Chat at the BTIG Virtual Biotechnology Conference finance.yahoo.com Aug 2, 2021 8:00 am Sensei downgraded, PT cut on program discontinuation, Gilead's Yescarta data, and more in analyst action seekingalpha.com Jun 29, 2021 9:55 pm Idera Pharmaceuticals, Beyond Air leads healthcare gainers; Mereo BioPharma, Portage Biotech among major losers seekingalpha.com Jun 22, 2021 11:02 pm
Mereo's Alvelestat Shows Encouraging Biomarker Data In Bronchiolitis Obliterans Syndrome finance.yahoo.com Jun 2, 2021 9:45 am
Mereo BioPharma to Participate in a Fireside Chat at the Jefferies 2021 Virtual Healthcare Conference finance.yahoo.com May 27, 2021 8:00 am Esperion sinks after Stifel downgrade, Community Health adds another bull; in today’s healthcare analyst action seekingalpha.com May 5, 2021 9:01 pm This company doesn't provide a dividend.
Talk about Mereo BioPharma Group plc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
